Presentation is loading. Please wait.

Presentation is loading. Please wait.

WHO Regional Office for Europe Vaccine preventable diseases and Immunization programme Measles containing vaccine (MCV1) coverage in the WHO European Region.

Published byRolf Manning Modified over 9 years ago

Similar presentations

Presentation on theme: "WHO Regional Office for Europe Vaccine preventable diseases and Immunization programme Measles containing vaccine (MCV1) coverage in the WHO European Region."— Presentation transcript:

1 WHO Regional Office for Europe Vaccine preventable diseases and Immunization programme Measles containing vaccine (MCV1) coverage in the WHO European Region 1990 Source; WHO/UNICEF Joint Reporting Form The designations employed and the presentation of this material do not imply the expression of any opinion whatsoever on the part of the Secretariat of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.

2 WHO Regional Office for Europe Vaccine preventable diseases and Immunization programme Measles containing vaccine (MCV1) coverage in the WHO European Region 1995 Source; WHO/UNICEF Joint Reporting Form The designations employed and the presentation of this material do not imply the expression of any opinion whatsoever on the part of the Secretariat of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.

3 WHO Regional Office for Europe Vaccine preventable diseases and Immunization programme Measles containing vaccine (MCV1) coverage in the WHO European Region 2000 Source; WHO/UNICEF Joint Reporting Form The designations employed and the presentation of this material do not imply the expression of any opinion whatsoever on the part of the Secretariat of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.

4 WHO Regional Office for Europe Vaccine preventable diseases and Immunization programme Measles containing vaccine (MCV1) coverage in the WHO European Region 2001 Source; WHO/UNICEF Joint Reporting Form The designations employed and the presentation of this material do not imply the expression of any opinion whatsoever on the part of the Secretariat of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.

5 WHO Regional Office for Europe Vaccine preventable diseases and Immunization programme Measles containing vaccine (MCV1) coverage in the WHO European Region 2002 Source; WHO/UNICEF Joint Reporting Form The designations employed and the presentation of this material do not imply the expression of any opinion whatsoever on the part of the Secretariat of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.

6 WHO Regional Office for Europe Vaccine preventable diseases and Immunization programme Measles containing vaccine (MCV1) coverage in the WHO European Region 2003 Source; WHO/UNICEF Joint Reporting Form The designations employed and the presentation of this material do not imply the expression of any opinion whatsoever on the part of the Secretariat of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.

7 WHO Regional Office for Europe Vaccine preventable diseases and Immunization programme Measles containing vaccine (MCV1) coverage in the WHO European Region 2004 Source; WHO/UNICEF Joint Reporting Form The designations employed and the presentation of this material do not imply the expression of any opinion whatsoever on the part of the Secretariat of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.

Download ppt "WHO Regional Office for Europe Vaccine preventable diseases and Immunization programme Measles containing vaccine (MCV1) coverage in the WHO European Region."

Similar presentations

WHO Regional Office for Europe Vaccine preventable diseases and Immunization programme Diphtheria Incidence in the WHO European Region 1990 Source; WHO/UNICEF.

WHO Regional Office for Europe Vaccine preventable diseases and Immunization programme Diphtheria Incidence in the WHO European Region 1990 Source; WHO/UNICEF.
1 |1 | Countries using and planning to introduce IPV July 2014 status report This slide deck provides a summary per country on the status of planning for.

1 |1 | Countries using and planning to introduce IPV July 2014 status report This slide deck provides a summary per country on the status of planning for.
1 |1 | Countries using and planning to introduce IPV.

1 |1 | Countries using and planning to introduce IPV.
Monitoring progress towards the coverage and disease incidence targets GLOBAL MEASLES AND RUBELLA MANAGEMENT MEETING 15-17 March 2011 Geneva, Switzerland.

Monitoring progress towards the coverage and disease incidence targets GLOBAL MEASLES AND RUBELLA MANAGEMENT MEETING March 2011 Geneva, Switzerland.
1 |1 | Countries using and planning to introduce IPV.

1 |1 | Countries using and planning to introduce IPV.
1 |1 | Countries using and planning to introduce IPV.

1 |1 | Countries using and planning to introduce IPV.
Vaccine in National Immunization Programme Update March 2015.

Vaccine in National Immunization Programme Update March 2015.
1 |1 | Countries using and planning to introduce IPV.

1 |1 | Countries using and planning to introduce IPV.
1 |1 | Countries using and planning to introduce IPV.

1 |1 | Countries using and planning to introduce IPV.
World Health Organization

World Health Organization
1 |1 | Countries using and planning to introduce IPV.

1 |1 | Countries using and planning to introduce IPV.
TITLE from VIEW and SLIDE MASTER | August 7, 2015 1 |1 | Countries with Hib vaccine in the national immunization programme; and planned introductions *

TITLE from VIEW and SLIDE MASTER | August 7, |1 | Countries with Hib vaccine in the national immunization programme; and planned introductions *
World Health Organization

World Health Organization
Reaching the 2010 Measles Mortality Reduction Goal-can SEARO get there? Meeting of the Partners for Measles Advocacy Washington DC, 23-24 September 2008.

Reaching the 2010 Measles Mortality Reduction Goal-can SEARO get there? Meeting of the Partners for Measles Advocacy Washington DC, September 2008.
Progress towards Sustainable Measles Mortality Reduction South-East Asia Region Jayantha Liyanage Medical Officer- EPI Immunization and Vaccine Development.

Progress towards Sustainable Measles Mortality Reduction South-East Asia Region Jayantha Liyanage Medical Officer- EPI Immunization and Vaccine Development.
1 |1 | Countries using and planning to introduce IPV.

1 |1 | Countries using and planning to introduce IPV.
Highlights of New WPV Cases 34 new cases in 5 countries 14 cases (14 W3) but no new district in India Most recent date of onset 03 Oct 1 case (W1) but.

Highlights of New WPV Cases 34 new cases in 5 countries 14 cases (14 W3) but no new district in India Most recent date of onset 03 Oct 1 case (W1) but.
Global Programme on Evidence for Health Policy Presentation by the Epidemiology and Burden of Disease Team of the World Health Organization at the United.

Global Programme on Evidence for Health Policy Presentation by the Epidemiology and Burden of Disease Team of the World Health Organization at the United.
1 |1 | Countries using and planning to introduce IPV.

1 |1 | Countries using and planning to introduce IPV.
1 Progress Towards Global and Regional Immunization Goals Workshop on Prevention and Control of Vaccine Preventable Disease in Displaced Person Temporary.

1 Progress Towards Global and Regional Immunization Goals Workshop on Prevention and Control of Vaccine Preventable Disease in Displaced Person Temporary.

Similar presentations

Ads by Google